4.6 Article

Requirements for PKC-augmented JNK activation by MKK4/7

Journal

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Volume 40, Issue 5, Pages 1055-1064

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.biocel.2007.11.011

Keywords

JNK; MKK4; MKK7; PKC; RACK1

Funding

  1. NCI NIH HHS [R01 CA051995-16A1, CA51995, R01 CA051995] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [R01CA051995, R29CA051995] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The c-Jun N-terminal kinases (JNKs) are activated in response to stress, DNA damage, and cytokines by MKK4 and MKK7. We recently demonstrated that PKC can augment the degree of JNK activation by phosphorylating JNK, which requires the adaptor protein RACK1. Here we report on the conditions required for PKC-dependent INK activation. In vitro kinase assays reveal that PKC phosphorylation of JNK is not sufficient for its activation but rather augments JNK activation by canonical JNK upstream kinases MKK4 or MKK7 alone or in combination. Further, to enhance JNK activity, PKC phosphorylation of JNK should precede its phosphorylation by MKK4/7. Inhibition of PKC phosphorylation of JNK affects both early and late phases of JNK activation following UV-irradiation and reduces the apoptotic response mediated by JNK. These data provide important insight into the requirements for PKC activation of INK signaling. (C) 2007 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Cell Biology

Rewired Notch/p53 by Numb'ing Mdm2

Hyungsoo Kim, Ze'ev A. Ronai

JOURNAL OF CELL BIOLOGY (2018)

Article Immunology

The mTORC1/4E-BP/eIF4E Axis Promotes Antibody Class Switching in B Lymphocytes

Honyin Chiu, Leandra V. Jackson, Kwon Ik Oh, Annie Mai, Ze'ev A. Ronai, Davide Ruggero, David A. Fruman

JOURNAL OF IMMUNOLOGY (2019)

Review Biochemistry & Molecular Biology

Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity

Yu Fujita, Roberto Tinoco, Yan Li, Daniela Senft, Ze'ev A. Ronai

TRENDS IN MOLECULAR MEDICINE (2019)

Article Oncology

Identification and characterization of small molecule inhibitors of the ubiquitin ligases Siah1/2 in melanoma and prostate cancer cells

Yongmei Feng, E. Hampton Sessions, Fan Zhang, Fuqiang Ban, Veronica Placencio-Hickok, Chen-Ting Ma, Fu-Yue Zeng, Ian Pass, David B. Terry, Gregory Cadwell, Laurie A. Bankston, Robert C. Liddington, Thomas D. Y. Chung, Anthony B. Pinkerton, Eduard Sergienko, Martin Gleave, Neil A. Bhowmick, Michael R. Jackson, Artem Cherkasov, Ze'ev A. Ronai

CANCER LETTERS (2019)

Article Multidisciplinary Sciences

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5-/- mice

Yan Li, Roberto Tinoco, Lisa Elmen, Igor Segota, Yibo Xian, Yu Fujita, Avinash Sahu, Raphy Zarecki, Kerrie Marie, Yongmei Feng, Ali Khateb, Dennie T. Frederick, Shiri K. Ashkenazi, Hyungsoo Kim, Eva Guijarro Perez, Chi-Ping Day, Rafael S. Segura Munoz, Robert Schmaltz, Shibu Yooseph, Miguel A. Tam, Tongwu Zhang, Emily Avitan-Hersh, Lihi Tzur, Shoshana Roizman, Ilanit Boyango, Gil Bar-Sela, Amir Orian, Randal J. Kaufman, Marcus Bosenberg, Colin R. Goding, Bas Baaten, Mitchell P. Levesque, Reinhard Dummer, Kevin Brown, Glenn Merlino, Eytan Ruppin, Keith Flaherty, Amanda Ramer-Tait, Tao Long, Scott N. Peterson, Linda M. Bradley, Ze'ev A. Ronai

NATURE COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

SIP/CacyBP promotes autophagy by regulating levels of BRUCE/Apollon, which stimulates LC3-I degradation

Tian-Xia Jiang, Jiang-Bo Zou, Qian-Qian Zhu, Cui Hua Liu, Guang-Fei Wang, Ting-Ting Du, Zi-Yu Luo, Fang Guo, Lu-Ming Zhou, Juan-Juan Liu, Wensheng Zhang, You-Sheng Shu, Li Yu, Peng Li, Ze'ev A. Ronai, Shu-ichi Matsuzawa, Alfred L. Goldberg, Xiao-Bo Qiu

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Cell Biology

Translational reprogramming marks adaptation to asparagine restriction in cancer

Gaurav Pathria, Joo Sang Lee, Erez Hasnis, Kristofferson Tandoc, David A. Scott, Sachin Verma, Yongmei Feng, Lionel Larue, Avinash D. Sahu, Ivan Topisirovic, Eytan Ruppin, Ze'ev A. Ronai

NATURE CELL BIOLOGY (2019)

Article Multidisciplinary Sciences

Siah2 control of T-regulatory cells limits anti-tumor immunity

Marzia Scortegagna, Kathryn Hockemeyer, Igor Dolgalev, Joanna Pozniak, Florian Rambow, Yan Li, Yongmei Feng, Roberto Tinoco, Dennis C. Otero, Tongwu Zhang, Kevin Brown, Marcus Bosenberg, Linda M. Bradley, Jean-Christophe Marine, Ioannis Aifantis, Ze'ev A. Ronai

NATURE COMMUNICATIONS (2020)

Review Neurosciences

The gut microbiome: an unexpected player in cancer immunity

Scott N. Peterson, Linda M. Bradley, Ze'ev A. Ronai

CURRENT OPINION IN NEUROBIOLOGY (2020)

Article Cell Biology

PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity

Hyungsoo Kim, Heejung Kim, Yongmei Feng, Yan Li, Hironari Tamiya, Stefania Tocci, Ze'ev A. Ronai

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Biochemistry & Molecular Biology

MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction

Gaurav Pathria, Sachin Verma, Jun Yin, David A. Scott, Ze'ev A. Ronai

Summary: Amino acid restriction is a promising cancer treatment strategy, but cancer cells develop mechanisms to resist this restriction. In melanoma cells with high asparagine levels, MAPK signaling activation impairs c-MYC degradation, leading to elevated c-MYC levels and enhanced ATF4 activation. Inhibiting the MAPK-c-MYC-SLC7A5 signaling axis can effectively suppress melanoma cell proliferation in combination with asparagine restriction.

EMBO REPORTS (2021)

Article Oncology

Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma

Yongmei Feng, Gaurav Pathria, Susanne Heynen-Genel, Michael Jackson, Brian James, Jun Yin, David A. Scott, Ze'ev A. Ronai

Summary: IMD-0354, a potent inhibitor of glutamine uptake, demonstrated significant effects on melanoma cell growth, inducing cell cycle arrest, autophagy, and apoptosis. The drug showed pronounced effects in various tumor cell lines compared to non-transformed cells, highlighting its potential as a therapeutic and experimental tool that warrants further exploration.

MOLECULAR CANCER THERAPEUTICS (2021)

News Item Biochemistry & Molecular Biology

Lipid metabolism: new twists to the Yin and Yang of PKM2 in cancer

Ali Khateb, Ze'ev A. Ronai

Summary: The study reveals the important role of PKM2 as a pyruvate kinase in regulating cancer cell cholesterol metabolism, demonstrating its diverse tissue-specific functions and potential implications for cancer treatment.

EMBO JOURNAL (2021)

Article Oncology

Ubiquitin Ligases Siah1a/2 Control Alveolar Macrophage Functions to Limit Carcinogen-Induced Lung Adenocarcinoma

Marzia Scortegagna, Yuanning Du, Linda M. Bradley, Kun Wang, Alfredo Molinolo, Eytan Ruppin, Rabi Murad, Ze'ev A. Ronai

Summary: Cellular components, such as myeloid cells, in the tumor microenvironment have significant impact on the progression and treatment response of lung adenocarcinoma (LUAD). This study reveals that the ubiquitin ligases Siah1a/2 regulate the differentiation and activity of alveolar macrophages (AM), and their control of AMs influences carcinogen-induced LUAD. The findings indicate that Siah1a/2 in AMs act as gatekeepers of lung cancer development by controlling inflammatory signaling, differentiation, and profibrotic phenotypes.

CANCER RESEARCH (2023)

Review Oncology

Ubiquitin ligases in oncogenic transformation and cancer therapy

Daniela Senft, Jianfei Qi, Ze'ev A. Ronai

NATURE REVIEWS CANCER (2018)

Article Biochemistry & Molecular Biology

CENPL accelerates cell proliferation, cell cycle, apoptosis, and glycolysis via the MEK1/2-ERK1/2 pathway in hepatocellular carcinoma

Kun He, Mengyi Xie, Weifeng Hong, Yonghe Li, Yaolin Yin, Xiaojin Gao, Yi He, Yu Chen, Chuan You, Jingdong Li

Summary: Centromere protein L (CENPL) is overexpressed in hepatocellular carcinoma (HCC) and is associated with poor patient prognosis. Upregulation of CENPL promotes tumor proliferation and glycolysis in HCC cells by activating the MEK1/2-ERK1/2 signaling pathway.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2024)

Article Biochemistry & Molecular Biology

Talin mechanotransduction in disease

Yingzi Wang, Haozhong Huang, Huimin Weng, Chunsen Jia, Bin Liao, Yang Long, Fengxu Yu, Yongmei Nie

Summary: Talin protein plays a crucial role in transmitting mechanical forces by connecting the extracellular matrix to the cytoskeleton. It converts mechanical signals into biochemical signals and serves as diagnostic, therapeutic, and prognostic indicators in diseases.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2024)

Review Biochemistry & Molecular Biology

ER-mitochondria contact sites in mitochondrial DNA dynamics, maintenance, and distribution

Hema Saranya Ilamathi, Marc Germain

Summary: Mitochondria are the central metabolic hubs in cells, relying on proteins encoded by nuclear DNA and mitochondrial DNA (mtDNA) for their function. The maintenance and distribution of mtDNA are crucial for proper mitochondrial function and are associated with mitochondrial diseases. mtDNA is organized into nucleoids that dynamically move and interact with each other. The replication and distribution of mtDNA nucleoids are regulated by the complex interplay of mitochondrial dynamics, ER-mitochondria contact sites, and cytoskeletal networks.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2024)

Article Biochemistry & Molecular Biology

Tumor protein D52 (isoform 3) induces NF-κB-STAT3 mediated EMT driving neuroendocrine differentiation of prostate cancer cells

K. K. Sruthi, Sirisha Natani, Ramesh Ummanni

Summary: The overexpression of TPD52 is associated with the emergence of neuroendocrine prostate cancer (NEPC). TPD52 activates the NF-kappa B - STAT3 axis to induce neuroendocrine differentiation (NED) of prostate cancer cells. Therapeutic targeting of TPD52 is important for the treatment of prostate cancer.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2024)

Article Biochemistry & Molecular Biology

Tumor-derived microparticles promoted M2-like macrophages polarization to stimulate osteosarcoma progression

Cui Li, Feifan Xiang, Yuqi Gong, Yi Fu, Ge Chen, Zhi Wang, Zhong Li, Daiqing Wei

Summary: Our study demonstrates the significant role of tumor-derived microparticles (T-MPs) in osteosarcoma metastasis and immune response. T-MPs promote macrophage polarization and stimulate migration and chemoresistance of osteosarcoma cells, thereby affecting the progression of osteosarcoma.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2024)